Sanofi-Sun Settlement In Eloxatin Suit Ruled Valid

Law360, New York (October 6, 2009, 7:14 PM EDT) -- A judge has ruled that Sanofi-Aventis is bound to a settlement agreement it reached with Sun Pharmaceutical Industries Ltd. in a patent infringement suit over generic versions of Sanofi’s popular colon cancer drug Eloxatin, even though it failed to sign the agreement.

In an order handed down Friday, Judge Joel Pisano of the U.S. District Court of New Jersey ruled that the settlement was valid even though Sanofi did not return signed copies of the agreement prior to the court’s June finding that defendants had not...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.